| Stock | PriceCurrent trading price. | Market CapTotal market capitalization. | FKPrice to Earnings ratio. | PD/DDPrice to Book ratio. | EV/EBITDAEnterprise Value / EBITDA. | ROICReturn on Invested Capital. | WACCWeighted Average Cost of Capital (WACC). | PUSLAFinancial health score (0-100). | DamodaranValuation score. | Intrinsic ValueFair value via DCF model. | Potential %Expected upside potential %. | Dalio RiskDalio Debt Cycle Score | Debt/EquityDebt to Equity ratio. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ORAS
|
822.50 | 96.0B | 11.68 | 2.53 | 4.92 | 16.4% | 37.4% | 65 | 52 | 1,426.93 | +55.1% | 64 | 0.59 |
|
SVCE
|
12.47 | 12.0B | — | 3.88 | 80.23 | — | — | 31 | 41 | 6.75 | -23.4% | 39 | 0.62 |
|
MENA
|
6.85 | 1.7B | — | 16.43 | — | -23.8% | 45.4% | 24 | 5 | 1.71 | -36.1% | 71 | 0.01 |
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.